Literature DB >> 1520582

Photodynamic therapy of the normal rat stomach: a comparative study between di-sulphonated aluminium phthalocyanine and 5-aminolaevulinic acid.

C S Loh1, J Bedwell, A J MacRobert, N Krasner, D Phillips, S G Bown.   

Abstract

Dysplasia in the upper gastrointestinal tract carries a risk of invasive malignant change. Surgical excision of the affected organ is the only treatment available. Photodynamic therapy has been shown to be promising in the treatment of early and superficial tumours and may be useful for the ablation of dysplastic mucosa. Because of the diffuse nature of the disease, such treatment would necessarily involve destruction of large areas of mucosa and it is desirable to confine its effect to the mucosa in order that safe healing can take place. By means of photometric fluorescence microscopy, we have studied the pattern of photosensitisation in the normal rat stomach using di-sulphonated aluminium phthalocyanine (AlS2Pc) and 5-aminolaevulinic acid (ALA) as photosensitisizers. AlS2Pc resulted in a panmural photosensitisation of the gastric wall with the highest level encountered in the submucosa. The mucosa and muscularis propria were sensitised to equal extent. Following light exposure, a full thickness damage resulted. ALA is a natural porphyrin precursor and exogenous administration gave rise to accumulation of protoporphyrin IX (PPIX) in the cells. The resultant pattern of photosensitisation was predominantly mucosal and its photodynamic effect was essentially confined to the mucosa. ALA produced a selective photosensitisation of the gastric mucosa for its photodynamic ablation with sparing the underlying tissue layers.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1520582      PMCID: PMC1977931          DOI: 10.1038/bjc.1992.295

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  46 in total

1.  Biological activities of phthalocyanines--VIII. Cellular distribution in V-79 Chinese hamster cells and phototoxicity of selectively sulfonated aluminum phthalocyanines.

Authors:  B Paquette; H Ali; R Langlois; J E van Lier
Journal:  Photochem Photobiol       Date:  1988-02       Impact factor: 3.421

2.  Ultrastructural studies on the mechanism of the photodynamic therapy of tumors.

Authors:  C Milanesi; R Biolo; E Reddi; G Jori
Journal:  Photochem Photobiol       Date:  1987-11       Impact factor: 3.421

3.  The contrasting mechanisms of colonic collagen damage between photodynamic therapy and thermal injury.

Authors:  H Barr; C J Tralau; P B Boulos; A J MacRobert; R Tilly; S G Bown
Journal:  Photochem Photobiol       Date:  1987-11       Impact factor: 3.421

4.  Evaluation of sulfonated aluminum phthalocyanines for use in photochemotherapy. Cellular uptake studies.

Authors:  K Berg; J C Bommer; J Moan
Journal:  Cancer Lett       Date:  1989-01       Impact factor: 8.679

5.  Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience.

Authors:  J C Kennedy; R H Pottier; D C Pross
Journal:  J Photochem Photobiol B       Date:  1990-06       Impact factor: 6.252

6.  Effect of sulfonation on the cell and tissue distribution of the photosensitizer aluminum phthalocyanine.

Authors:  W S Chan; J F Marshall; R Svensen; J Bedwell; I R Hart
Journal:  Cancer Res       Date:  1990-08-01       Impact factor: 12.701

7.  Endoscopic photodynamic therapy with hematoporphyrin derivative for primary treatment of gastrointestinal neoplasms in inoperable patients.

Authors:  T Patrice; M T Foultier; S Yactayo; F Adam; J P Galmiche; M C Douet; L Le Bodic
Journal:  Dig Dis Sci       Date:  1990-05       Impact factor: 3.199

8.  Use of charge coupled device camera for imaging of intracellular phthalocyanines.

Authors:  W S Chan; A J MacRobert; D Phillips; I R Hart
Journal:  Photochem Photobiol       Date:  1989-11       Impact factor: 3.421

9.  The theory of photodynamic therapy dosimetry: consequences of photo-destruction of sensitizer.

Authors:  W R Potter; T S Mang; T J Dougherty
Journal:  Photochem Photobiol       Date:  1987-07       Impact factor: 3.421

10.  Photodynamic therapy in the normal rat colon with phthalocyanine sensitisation.

Authors:  H Barr; C J Tralau; A J MacRobert; N Krasner; P B Boulos; C G Clark; S G Bown
Journal:  Br J Cancer       Date:  1987-08       Impact factor: 7.640

View more
  16 in total

Review 1.  Current concepts in gastrointestinal photodynamic therapy.

Authors:  J Webber; M Herman; D Kessel; D Fromm
Journal:  Ann Surg       Date:  1999-07       Impact factor: 12.969

2.  Pharmacokinetics of aminolevulinic acid after intravesical administration to dogs.

Authors:  J T Dalton; D Zhou; A Mukherjee; D Young; E A Tolley; A L Golub; M C Meyer
Journal:  Pharm Res       Date:  1999-02       Impact factor: 4.200

3.  Mucosal ablation using photodynamic therapy for the treatment of dysplasia: an experimental study in the normal rat stomach.

Authors:  C S Loh; A J MacRobert; G Buonaccorsi; N Krasner; S G Bown
Journal:  Gut       Date:  1996-01       Impact factor: 23.059

Review 4.  Clinical applications of 5-aminolevulinic acid-mediated fluorescence for gastric cancer.

Authors:  Tsutomu Namikawa; Tomoaki Yatabe; Keiji Inoue; Taro Shuin; Kazuhiro Hanazaki
Journal:  World J Gastroenterol       Date:  2015-08-07       Impact factor: 5.742

Review 5.  Current status of photodynamic therapy in oncology.

Authors:  R van Hillegersberg; W J Kort; J H Wilson
Journal:  Drugs       Date:  1994-10       Impact factor: 9.546

6.  Photodynamic therapy on the normal rabbit larynx with phthalocyanine and 5-aminolaevulinic acid induced protoporphyrin IX photosensitisation.

Authors:  D Kleemann; A J MacRobert; T Mentzel; P M Speight; S G Bown
Journal:  Br J Cancer       Date:  1996-07       Impact factor: 7.640

7.  Biological activities of phthalocyanines--XVI. Tetrahydroxy- and tetraalkylhydroxy zinc phthalocyanines. Effect of alkyl chain length on in vitro and in vivo photodynamic activities.

Authors:  R W Boyle; C C Leznoff; J E van Lier
Journal:  Br J Cancer       Date:  1993-06       Impact factor: 7.640

8.  Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer.

Authors:  F Cairnduff; M R Stringer; E J Hudson; D V Ash; S B Brown
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640

9.  The effect of aminolaevulinic acid-induced, protoporphyrin IX-mediated photodynamic therapy on the cremaster muscle microcirculation in vivo.

Authors:  J Leveckis; N J Brown; M W Reed
Journal:  Br J Cancer       Date:  1995-11       Impact factor: 7.640

10.  Enhancement of photodynamic therapy with 5-aminolaevulinic acid-induced porphyrin photosensitisation in normal rat colon by threshold and light fractionation studies.

Authors:  H Messmann; P Mlkvy; G Buonaccorsi; C L Davies; A J MacRobert; S G Bown
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.